1152035-02-3

Basic information

• Product Name: 2-(3-bromophenyl)-N-cyclohexylimidazolo[1,2-a]pyridin-3-amine
• Synonyms: 2-(3-bromophenyl)-N-cyclohexylimidazolo[1,2-a]pyridin-3-amine
• CAS NO: 1152035-02-3
• Molecular Weight: 370.292
• Mol File: 1152035-02-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-(3-bromophenyl)-N-cyclohexylimidazolo[1,2-a]pyridin-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-bromophenyl)-N-cyclohexylimidazolo[1,2-a]pyridin-3-amine(1152035-02-3)
• EPA Substance Registry System: 2-(3-bromophenyl)-N-cyclohexylimidazolo[1,2-a]pyridin-3-amine(1152035-02-3)

Safety Data

• Hazardous Substances Data: 1152035-02-3(Hazardous Substances Data)

Upstream product

• 504-29-0 2-aminopyridine 
• 931-53-3 Cyclohexyl isocyanide 
• 3132-99-8 m-bromobenzoic aldehyde 

Downstream Products

• 504-29-0 2-aminopyridine 

Relevant articles and documents

Magnetic mesoporous poly-melamine–formaldehyde: an efficient and recyclable catalyst for straightforward one-pot synthesis of imidazo[1,2-a]pyridines

Abstract: Magnetically separable mesoporous poly-melamine–formaldehyde nanocomposite (Fe3O4@mPMF) has been synthesized and characterized by FTIR spectroscopy, SEM, XRD spectroscopy and EDS. The magnetically separable Fe3O

Three novel sequential reactions for the facile synthesis of a library of bisheterocycles possessing the 3-aminoimidazo[1,2- a ]pyridine core catalyzed by bismuth(III) chloride

Novel, one-pot, two-step, sequential protocols for the synthesis of 1,4-phenylene bisheterocyclic compounds have been developed. Successive sequencing of the Groebke-Blackburn-Bienaymé reaction with Ugi-azide, Hantzsch and Biginelli reactions results in rapid and efficient formation of bisheterocyclic compounds. A simple, fast and high yielding method for the synthesis of 3-aminoimidazo[1,2-a]pyridines catalyzed by bismuth(III) chloride under solvent-free conditions is reported. Bismuth(III) chloride is also an efficient catalyst for the Ugi-azide reaction under solvent free conditions. Georg Thieme Verlag Stuttgart - New York.

IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS

The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.